Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ATRC > SEC Filings for ATRC > Form 8-K on 13-Feb-2014All Recent SEC Filings

Show all filings for ATRICURE, INC.

Form 8-K for ATRICURE, INC.


Entry into a Material Definitive Agreement, Financial Statements and Exhibits

Item 1.01. Entry Into a Material Definitive Agreement.

On February 13, 2014, AtriCure, Inc. ("AtriCure" or the "Company") entered into a purchase agreement (the "Purchase Agreement") with Piper Jaffray & Co. (the "Underwriter") and certain selling shareholders listed therein (the "Selling Shareholders") relating to the sale (the "Offering") of shares of AtriCure Common Stock, par value $0.001 per share (the "Shares"). Pursuant to the Purchase Agreement, the Company agreed to issue and sell 3,023,025 Shares to the Underwriter and the Selling Shareholders agreed to sell 1,226,975 Shares (the "Selling Shareholder Shares") to the Underwriter, each at a public offering price of $19.25 per share. Pursuant to the Purchase Agreement, the Company also granted the Underwriter the right to purchase an additional 637,500 Shares within 30 days of February 13, 2014 to cover over-allotments, if any.

The Company estimates that it will receive net proceeds of approximately $54.4 million from the Offering after deducting underwriting discounts and commissions and offering expenses. The Company will not receive any proceeds from the sale of the Selling Shareholder Shares. The Company intends to use the net proceeds from the Offering for general corporate purposes and working capital. The Offering is subject to customary closing conditions and is expected to close on or about February 19, 2014.

The foregoing is only a brief description of the material terms of the Purchase Agreement and does not purport to be a complete description of the rights and obligations of the parties thereunder and is qualified in its entirety by reference to the Purchase Agreement, which is filed hereto as Exhibit 1.1 and incorporated by reference herein.

The legal opinion, including the related consent, of Keating Muething & Klekamp PLL relating to the issuance of the Shares is filed as Exhibit 5.1 to this Current Report on Form 8-K.

On February 12, 2014, we issued a press release announcing that we had commenced the Offering. On February 13, 2014, we issued a press release announcing that we had priced the Offering. The press releases are attached hereto as Exhibits 99.1 and 99.2, respectively.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.                                   Description

 1.1              Purchase Agreement dated February 13, 2014.

 5.1              Opinion of Keating Muething & Klekamp PLL.

23.1              Consent of Keating Muething & Klekamp PLL (included in Exhibit 5.1).

99.1              Press Release of AtriCure, Inc. dated February 12, 2014.

99.2              Press Release of AtriCure, Inc. dated February 13, 2014.

  Add ATRC to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ATRC - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.